Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
08/2003
08/27/2003EP1337262A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
08/27/2003EP1337236A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
08/27/2003EP1337228A2 Compositions for removing human cerumen
08/27/2003EP1071435A4 Silicate-containing powders providing controlled, sustained gas release
08/27/2003EP0942720B1 Use of metal complexes to treat gastrointestinal infections
08/27/2003CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
08/27/2003CN1437968A Heat-clearing and stagnation-dissipating particle medicine and preparation method
08/27/2003CN1437841A Culturing method for biological selenium products
08/27/2003CN1119291C Method of production of medical electrolysed water and dialysis apparatus using water asdialysis liquid
08/27/2003CN1119165C Health-care drink of nourishing spleen and kidney
08/27/2003CN1119159C Medicine for curing stomatocase
08/27/2003CN1119155C Chinese medicine composition for treating damaged skin
08/27/2003CN1119153C Injection for treating tumor in respiratory system and its appliation
08/27/2003CN1119152C Injection for treating tumor in digestive system and its application
08/27/2003CN1119108C Method of producing health wine utensil for Chinese medicine wine
08/26/2003US6610699 Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
08/26/2003US6610673 Solid dose forms containing bismuth
08/26/2003US6610325 Pharmaceutical medicine comprises an iron salt, not less than two polyols, a binding agent, a lubricating agent, and a flavoring agent. The dose of elemental iron is not less than 5 mg, and preferably 10 mg to 15 mg per tablet. The polyols are
08/26/2003US6610206 Buffered compositions for dialysis
08/21/2003WO2003068777A1 Aluminium and hexamethylenetetramine complex and the applications thereof
08/21/2003WO2003068270A1 Method of radio-labelling biomolecules
08/21/2003WO2003068247A1 Eye installation based on iodine anions
08/21/2003WO2003068246A2 Improvements in or relating to compositions
08/21/2003WO2003068213A1 Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood
08/21/2003WO2003068200A2 Novel therapeutic application for a composition
08/21/2003WO2002100329A3 Methods and compositions for helping the body resist the effects of the aging process
08/21/2003WO2002085384A3 Lubricious coatings for substrates
08/21/2003US20030158459 Enhanced formulations for neutraliztion of chemical, biological and industrial toxants
08/21/2003US20030158255 Use of bismuth subgallate in prevention and/or reduction of skin deterioration
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158165 Wound treatment solution and method for using same
08/21/2003US20030157560 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
08/21/2003US20030157196 Compositions and methods for creating an air release mechanism to maintain skin health
08/21/2003US20030157195 Composition and method for treating diaper rashes and skin irritations caused by acidic secretions
08/21/2003US20030157194 Method for treating cellulite
08/21/2003US20030157191 Administering to a subject undergoing chemotherapy an amount of a chemoprotectant
08/21/2003US20030157190 Administering bioavailable and physiologically acceptable zinc salt
08/21/2003US20030157188 Bactericide solution and method of making same
08/21/2003US20030157187 Compositions and methods for treating or preventing inflammatory diseases
08/21/2003US20030157185 Treatment of symptoms of diseases relating to restricted blood flow to nerve endings and lower extremities such as fobromyalgia by topical application of composition comprising plant extracts
08/21/2003US20030157176 Silver-based antimicrobial agent which dissociates silver ions in water and silver ion trapping agent for trapping silver ions, comprising purine and pyrimidine bases, thiabendazole, and potassium iodide; external skin agents, cosmetics
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157088 Mixture of enzyme and enzyme inhibitors
08/21/2003CA2475522A1 Method of radio-labelling biomolecules
08/20/2003EP1335734A1 Method for treating hiv
08/20/2003EP1335726A1 Modified prodrug forms of ap/amp
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP0679401B1 Composition for curing lesioned tissue, process for producing the same, and use thereof
08/20/2003EP0612248B1 Composition containing cisplatin and topotecan as antitumor agent.
08/20/2003CN1437485A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
08/20/2003CN1436564A Liver cancer treating medicine and its prepn
08/20/2003CN1436558A Plaster for treating pain and swelling
08/20/2003CN1118285C Plaster for treating wind-cold arthritis with fixed pain caused by dampness
08/20/2003CN1118284C Medicinal composition for treating beriberi and preparing process thereof
08/20/2003CN1118283C Gastropathy treating medicine and its prepn.
08/20/2003CN1118282C Method for preparing calcium replenishing liquid with composite function
08/20/2003CN1118238C Bactericidal agent containing iron ions
08/19/2003US6608203 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
08/19/2003US6608043 Administering complex of hyaluronic acid and zinc to patient having arthritic disease
08/19/2003US6607749 Non-fermentable methyl cellulose, lipase inhibitor and edible calcium phosphate salt; fecal incontinence, obesity
08/19/2003US6607743 Milk-derived basic cystatins or decomposition products; foods, beverages, feeds
08/19/2003US6607716 Natural treatment for ecto-parasitic infestation, particularly effective against lice be it head, body or pubic. A preferred gel composition includes a salt, a plant essence, and a pharmaceutically acceptable gelling agent.
08/19/2003US6607151 Cleaning compounds, cosmetics; controlling particle size; filtration
08/19/2003CA2100777C Pharmaceutical composition containing granisetron and dexamethasone
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066071A1 Formulations comprising psychotropic drugs and selenium
08/14/2003WO2003066070A1 Method and apparatus for treating water for use in improving the intestinal flora of livestock and poultry
08/14/2003WO2003066067A2 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003WO2003066064A2 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics
08/14/2003WO2003066059A1 Treatment of neuroblastoma
08/14/2003WO2003066022A2 Stable pharmaceutical composition useful for treating gastrointestinal disorders
08/14/2003WO2003032973A3 Composition comprising paracetamol and a bitterness masking component
08/14/2003WO2002048154A9 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153086 Such as iron hydroxide and sodium iron gluconate in glucose; blood disorders; storage stability
08/14/2003US20030152642 Mixture of chondroitin sulfate, glucosamine and hyaluronic acid
08/14/2003US20030152622 Formulation of an erodible, gastric retentive oral diuretic
08/14/2003US20030152596 Mixture of elastase inhibitor and fungicide or bactericide; antiinflammatory agent
08/14/2003US20030152530 Aqueous solution of calcium ions and stabilising agent, aqueous solution of phosphate ions and stabilising agent wherein calcium and phosphate ions are present in amounts sufficient to form on mixing a supersaturated solution thereof
08/14/2003DE10201747C1 Glas-Keramik-Komposit, Verfahren zu seiner Herstellung und Verwendungen Glass-ceramic composite, method for its preparation and uses
08/14/2003CA2475209A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003CA2475066A1 Rhamnose binding protein
08/13/2003EP1333865A1 Inorganic low density radionuclide coated particles
08/13/2003EP1154690B1 Composition for generating chlorine dioxide
08/13/2003EP1132090B1 Method for producing an agent for treating ulcers of the organism
08/13/2003CN1436072A Composition, kits, and methods for promoting defined health benefits
08/13/2003CN1435202A Medicine for treating child diarrhea
08/13/2003CN1435191A Chinese medicine for bone-knitting and method for preparing same
08/13/2003CN1117572C Medicine powder for treating athlete's foot, smelly foot and sweaty foot
08/13/2003CN1117571C Improved calcium dietary supplement
08/13/2003CN1117562C Compositions and method for controlling smoking
08/13/2003CN1117561C Compounded calcium preparation, preparing method and use thereof
08/12/2003US6605751 Silver-containing compositions, devices and methods for making
08/12/2003US6605666 Polyurethane film-forming dispersions in alcohol-water system
08/12/2003US6605606 Solid forms of tin ethyl etiopurpurin and processes for producing such forms
08/12/2003US6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
08/12/2003US6605304 Silicate-containing powders providing controlled, sustained gas release
08/12/2003US6605291 Containing spinels